Hesperetin protects against cardiac remodelling induced by pressure overload in mice.

Journal of molecular histology

Volumn 44, Issue 5, 2013, Pages 575-585

  Deng, Wei ^a   Jiang, Duan ^b   Fang, Y ^b   Zhou, Heng ^b   Cheng, Zhihong ^b   Lin, Yafen ^b   Zhang, Rui ^b   Zhang, Jieyu ^b   Pu, Peng ^b   Liu, Yuan ^b   Bian, Zhouyan ^b   Tang, Qizhu ^b  

^a WUHAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT; HESPERETIN; HESPERIDIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; BODY WEIGHT; C57BL MOUSE; CARDIOMEGALY; DRUG EFFECTS; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; MALE; METABOLISM; MOUSE; ORGAN SIZE; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BODY WEIGHT; CARDIOMEGALY; CARDIOTONIC AGENTS; FIBROSIS; GENE EXPRESSION REGULATION; HEART; HESPERIDIN; MALE; MAP KINASE KINASE 4; MICE; MICE, INBRED C57BL; ORGAN SIZE; OXIDATIVE STRESS; PROTEIN KINASE C BETA; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 84899041345     PISSN: None     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-013-9514-7     Document Type: Article

References (39)

1. CL Antos TA McKinsey N Frey 2002 Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo Proc Natl Acad Sci USA 99 907 912 11782539 10.1073/pnas.231619298 1:CAS:528:DC%2BD38Xht1WisLY%3D Antos CL, McKinsey TA, Frey N et al (2002) Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 99:907–912
2. SP Barry PA Townsend 2010 What causes a broken heart–molecular insights into heart failure Int Rev Cell Mol Biol 284 113 179 20875630 10.1016/S1937-6448(10)84003-1 1:CAS:528:DC%2BC3cXhs1Sis7%2FF Barry SP, Townsend PA (2010) What causes a broken heart–molecular insights into heart failure. Int Rev Cell Mol Biol 284:113–179
3. BC Berk K Fujiwara S Lehoux 2007 ECM remodeling in hypertensive heart disease J Clin Invest 117 568 575 17332884 10.1172/JCI31044 1:CAS:528:DC%2BD2sXis12htr0%3D Berk BC, Fujiwara K, Lehoux S (2007) ECM remodeling in hypertensive heart disease. J Clin Invest 117:568–575
4. BC Bernardo KL Weeks L Pretorius JR McMullen 2010 Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies Pharmacol Ther 128 191 227 20438756 10.1016/j.pharmthera.2010.04.005 1:CAS:528:DC%2BC3cXhtFGjtrrL Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128:191–227
5. E Bisping S Ikeda SW Kong 2006 Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure Proc Natl Acad Sci USA 103 14471 14476 16983087 10.1073/pnas.0602543103 1:CAS:528:DC%2BD28XhtVOgsbrL Bisping E, Ikeda S, Kong SW et al (2006) Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci USA 103:14471–14476
6. JR Burgoyne H Mongue-Din P Eaton AM Shah 2012 Redox signaling in cardiac physiology and pathology Circ Res 111 1091 1106 23023511 10.1161/CIRCRESAHA.111.255216 1:CAS:528:DC%2BC38XhsVWmt7%2FO Burgoyne JR, Mongue-Din H, Eaton P, Shah AM (2012) Redox signaling in cardiac physiology and pathology. Circ Res 111:1091–1106
7. AH Chaanine D Jeong L Liang 2012 JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure Cell Death Dis 3 265 22297293 10.1038/cddis.2012.5 1:STN:280:DC%2BC387ps1ehsA%3D%3D Chaanine AH, Jeong D, Liang L et al (2012) JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure. Cell Death Dis 3:265
8. B DeBosch N Sambandam C Weinheimer M Courtois AJ Muslin 2006 Akt2 regulates cardiac metabolism and cardiomyocyte survival J Biol Chem 281 32841 32851 16950770 10.1074/jbc.M513087200 1:CAS:528:DC%2BD28XhtFSrtrrP DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ (2006) Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 281:32841–32851
9. W Deng J Zong Z Bian 2013 Indole-3-carbinol protects against pressure overload induced cardiac remodeling via activating AMPK-alpha Mol Nutr Food Res 10.1002/mnfr.201300012 Deng W, Zong J, Bian Z et al (2013) Indole-3-carbinol protects against pressure overload induced cardiac remodeling via activating AMPK-alpha. Mol Nutr Food Res. doi: 10.1002/mnfr.201300012
10. GC Fan Q Yuan G Song 2006 Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1 Circ Res 99 1233 1242 17068291 10.1161/01.RES.0000251074.19348.af 1:CAS:528:DC%2BD28Xht1antr3K Fan GC, Yuan Q, Song G et al (2006) Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1. Circ Res 99:1233–1242
11. X Fan S Turdi SP Ford 2011 Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheep J Nutr Biochem 22 30 37 20188535 10.1016/j.jnutbio.2009.11.006 1:CAS:528:DC%2BC3cXhsFGhtbvJ Fan X, Turdi S, Ford SP et al (2011) Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheep. J Nutr Biochem 22:30–37
12. SR Houser KB Margulies AM Murphy 2012 Animal models of heart failure: a scientific statement from the American Heart Association Circ Res 111 131 150 22595296 10.1161/RES.0b013e3182582523 1:CAS:528:DC%2BC38XhtVeru7nP Houser SR, Margulies KB, Murphy AM et al (2012) Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 111:131–150
13. LM Keranen EM Dutil AC Newton 1995 Protein kinase C is regulated in vivo by three functionally distinct phosphorylations Curr Biol 5 1394 1403 8749392 10.1016/S0960-9822(95)00277-6 1:CAS:528:DyaK28XhtVehtQ%3D%3D Keranen LM, Dutil EM, Newton AC (1995) Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr Biol 5:1394–1403
14. JY Kim KJ Jung JS Choi HY Chung 2006 Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin Aging Cell 5 401 411 16939486 10.1111/j.1474-9726.2006.00233.x 1:CAS:528:DC%2BD28XhtFSisb3I Kim JY, Jung KJ, Choi JS, Chung HY (2006a) Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 5:401–411
15. JY Kim KJ Jung JS Choi HY Chung 2006 Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin Aging Cell 5 401 411 16939486 10.1111/j.1474-9726.2006.00233.x 1:CAS:528:DC%2BD28XhtFSisb3I Kim JY, Jung KJ, Choi JS, Chung HY (2006b) Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 5:401–411
16. HL Li AB Wang Y Huang 2005 Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways Free Radic Biol Med 38 243 257 15607907 10.1016/j.freeradbiomed.2004.10.020 Li HL, Wang AB, Huang Y et al (2005) Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 38:243–257
17. P Li D Wang J Lucas 2008 Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts Circ Res 102 185 192 17991884 10.1161/CIRCRESAHA.107.157677 1:CAS:528:DC%2BD1cXhtVGktL0%3D Li P, Wang D, Lucas J et al (2008) Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102:185–192
18. Q Liang JD Molkentin 2003 Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models J Mol Cell Cardiol 35 1385 1394 14654364 10.1016/j.yjmcc.2003.10.001 1:CAS:528:DC%2BD3sXpsVSnsL8%3D Liang Q, Molkentin JD (2003) Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 35:1385–1394
19. JR McMullen MC Sherwood O Tarnavski 2004 Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload Circulation 109 3050 3055 15184287 10.1161/01.CIR.0000130641.08705.45 1:CAS:528:DC%2BD2cXltVCjsbw%3D McMullen JR, Sherwood MC, Tarnavski O et al (2004) Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 109:3050–3055
20. B Morin LA Nichols KM Zalasky JW Davis JA Manthey LJ Holland 2008 The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells J Nutr 138 1274 1281 18567747 1:CAS:528:DC%2BD1cXnsVOltL8%3D Morin B, Nichols LA, Zalasky KM, Davis JW, Manthey JA, Holland LJ (2008) The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells. J Nutr 138:1274–1281
21. YG Ni K Berenji N Wang 2006 Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling Circulation 114 1159 1168 16952979 10.1161/CIRCULATIONAHA.106.637124 1:CAS:528:DC%2BD28XptVOrtr4%3D Ni YG, Berenji K, Wang N et al (2006) Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 114:1159–1168
22. Y Octavia RHP Brunner-La AL Moens 2012 NADPH oxidase-dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic approach Free Radic Biol Med 52 291 297 22080085 10.1016/j.freeradbiomed.2011.10.482 1:CAS:528:DC%2BC38XlsVyisg%3D%3D Octavia Y, Brunner-La RHP, Moens AL (2012) NADPH oxidase-dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic approach. Free Radic Biol Med 52:291–297
23. A Palfi A Toth K Hanto 2006 PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway J Mol Cell Cardiol 41 149 159 16716347 10.1016/j.yjmcc.2006.03.427 1:CAS:528:DC%2BD28Xms1antLg%3D Palfi A, Toth A, Hanto K et al (2006) PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. J Mol Cell Cardiol 41:149–159
24. L Pari K Shagirtha 2012 Hesperetin protects against oxidative stress related hepatic dysfunction by cadmium in rats Exp Toxicol Pathol 64 513 520 21134734 10.1016/j.etp.2010.11.007 1:CAS:528:DC%2BC38XmsVGkt7Y%3D Pari L, Shagirtha K (2012) Hesperetin protects against oxidative stress related hepatic dysfunction by cadmium in rats. Exp Toxicol Pathol 64:513–520
25. A Sabri SF Steinberg 2003 Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure Mol Cell Biochem 251 97 101 14575310 10.1023/A:1025490017780 1:CAS:528:DC%2BD3sXovFCgtbY%3D Sabri A, Steinberg SF (2003) Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol Cell Biochem 251:97–101
26. EP Scholz E Zitron C Kiesecker 2007 Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656 Nutr Metab Cardiovasc Dis 17 666 675 16926094 10.1016/j.numecd.2006.06.002 1:CAS:528:DC%2BD1cXksVamtLY%3D Scholz EP, Zitron E, Kiesecker C et al (2007) Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656. Nutr Metab Cardiovasc Dis 17:666–675
27. AM Shah DL Mann 2011 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science Lancet 378 704 712 21856484 10.1016/S0140-6736(11)60894-5 1:CAS:528:DC%2BC3MXhtVGmtr3I Shah AM, Mann DL (2011) In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378:704–712
28. CH Shih LH Lin HT Hsu 2012 Hesperetin, a selective phosphodiesterase 4 inhibitor, effectively suppresses ovalbumin-induced airway hyperresponsiveness without influencing xylazine/ketamine-induced anesthesia Evid Based Complement Alternat Med 2012 472897 22454667 Shih CH, Lin LH, Hsu HT et al (2012) Hesperetin, a selective phosphodiesterase 4 inhibitor, effectively suppresses ovalbumin-induced airway hyperresponsiveness without influencing xylazine/ketamine-induced anesthesia. Evid Based Complement Alternat Med 2012:472897
29. SS Singh PM Kang 2011 Mechanisms and inhibitors of apoptosis in cardiovascular diseases Curr Pharm Des 17 1783 1793 21631422 10.2174/138161211796390994 1:CAS:528:DC%2BC3MXhtVKqtrbN Singh SS, Kang PM (2011) Mechanisms and inhibitors of apoptosis in cardiovascular diseases. Curr Pharm Des 17:1783–1793
30. C Skurk Y Izumiya H Maatz 2005 The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling J Biol Chem 280 20814 20823 15781459 10.1074/jbc.M500528200 1:CAS:528:DC%2BD2MXktlCltr8%3D Skurk C, Izumiya Y, Maatz H et al (2005) The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 280:20814–20823
31. W Soesanto HY Lin E Hu 2009 Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats Hypertension 54 1321 1327 19884565 10.1161/HYPERTENSIONAHA.109.138818 1:CAS:528:DC%2BD1MXhtl2qurnK Soesanto W, Lin HY, Hu E et al (2009) Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 54:1321–1327
32. PP Trivedi S Kushwaha DN Tripathi GB Jena 2011 Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat Cardiovasc Toxicol 11 215 225 21553131 10.1007/s12012-011-9114-2 1:CAS:528:DC%2BC3MXps1egs7c%3D Trivedi PP, Kushwaha S, Tripathi DN, Jena GB (2011) Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat. Cardiovasc Toxicol 11:215–225
33. N Wang P Guan JP Zhang 2011 Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways J Cell Biochem 112 1920 1929 21433064 10.1002/jcb.23112 1:CAS:528:DC%2BC3MXntVyktr4%3D Wang N, Guan P, Zhang JP et al (2011) Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways. J Cell Biochem 112:1920–1929
34. WW Wong H Puthalakath 2008 Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway IUBMB Life 60 390 397 18425793 10.1002/iub.51 1:CAS:528:DC%2BD1cXhtlKnu7vN Wong WW, Puthalakath H (2008) Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life 60:390–397
35. L Yan H Huang QZ Tang 2010 Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling J Cell Biochem 109 1158 1171 20127712 1:CAS:528:DC%2BC3cXktFyqsro%3D Yan L, Huang H, Tang QZ et al (2010) Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling. J Cell Biochem 109:1158–1171
36. HL Yang SC Chen KKJ Senthil 2012 Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach J Agric Food Chem 60 522 532 22098419 10.1021/jf2040675 1:CAS:528:DC%2BC3MXhsVyrs77F Yang HL, Chen SC, Senthil KKJ et al (2012) Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach. J Agric Food Chem 60:522–532
37. L Ye FL Chan S Chen LK Leung 2012 The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice J Nutr Biochem 23 1230 1237 22209285 10.1016/j.jnutbio.2011.07.003 1:CAS:528:DC%2BC38XhtlGqtbnP Ye L, Chan FL, Chen S, Leung LK (2012) The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice. J Nutr Biochem 23:1230–1237
38. H Yoshida N Takamura T Shuto 2010 The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF-alpha in mouse adipocytes Biochem Biophys Res Commun 394 728 732 20230793 10.1016/j.bbrc.2010.03.060 1:CAS:528:DC%2BC3cXks1Kisbo%3D Yoshida H, Takamura N, Shuto T et al (2010) The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF-alpha in mouse adipocytes. Biochem Biophys Res Commun 394:728–732
39. J Zong W Deng H Zhou 2013 3,3′-Diindolylmethane Protects against Cardiac Hypertrophy via 5′-Adenosine Monophosphate-Activated Protein Kinase-alpha2 PLoS One 8 e53427 23326427 10.1371/journal.pone.0053427 1:CAS:528:DC%2BC3sXht1SltrY%3D Zong J, Deng W, Zhou H et al (2013) 3,3′-Diindolylmethane Protects against Cardiac Hypertrophy via 5′-Adenosine Monophosphate-Activated Protein Kinase-alpha2. PLoS One 8:e53427